Can a One-Time Anti-Inflammatory shot during surgery curb Triple-Negative breast Cancer's return?
Disease control
Not yet recruiting
This phase 3 trial tests whether a single dose of SRG-514 (ketorolac), given directly into the area where a breast tumor is removed, can help prevent cancer from coming back. The study enrolls adults with stage II-III triple-negative breast cancer who are having breast-conserving…
Phase: PHASE3 • Sponsor: SURGE Therapeutics • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC